Jennifer Straumins, a director at $CLMT, sold 100,000 shares of the company on 06-05-2025 for an estimated $1,317,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 8.4% of their shares of this class of stock. Following this trade, they now own 1,084,589 shares of this class of $CLMT stock.
$CLMT Insider Trading Activity
$CLMT insiders have traded $CLMT stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CLMT stock by insiders over the last 6 months:
- JENNIFER STRAUMINS has made 0 purchases and 2 sales selling 137,861 shares for an estimated $2,127,982.
- DANIEL L SHEETS has made 0 purchases and 4 sales selling 40,000 shares for an estimated $554,200.
- STEPHEN P MAWER has made 0 purchases and 4 sales selling 29,594 shares for an estimated $127,230.
- DAVID LUNIN (EVP - CFO) purchased 2,500 shares for an estimated $32,625
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLMT Hedge Fund Activity
We have seen 0 institutional investors add shares of $CLMT stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- IFP ADVISORS, INC removed 2,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $44,040
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLMT Analyst Ratings
Wall Street analysts have issued reports on $CLMT in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Sell" rating on 02/04/2025
To track analyst ratings and price targets for $CLMT, check out Quiver Quantitative's $CLMT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
